Literature DB >> 10844519

Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.

B F Qian1, M El-Salhy, S Melgar, M L Hammarström, A Danielsson.   

Abstract

Neuroendocrine peptides have a variety of physiological functions in the gastrointestinal tract. This study was carried out to investigate the impact of IL-2 deficiency on the neuroendocrine system in normal colon, and the neuroendocrine changes during colonic inflammation. Mice with homozygous disrupted IL-2 gene (IL-2-/-) spontaneously developed a bowel disease with similarities to human ulcerative colitis. Different types of colonic endocrine cells and myenteric nerves were analysed in the IL-2-/- mice using immunomorphometry. The neuropeptide contents in the colonic tissues were determined by radioimmunoassay. Age-matched healthy IL-2+/- and IL-2+/+ mice served as controls and the colonic IL-2 levels were compared between these two groups of mice by ELISA. Our data showed that less than half the amount of IL-2 was synthesized in the colon of IL-2+/- mice compared with the IL-2+/+ wild-type mice. Two major differences in the neuroendocrine colon were found between the mice with an intact and disrupted IL-2 gene. One was age-related. The frequencies of various endocrine cells and myenteric nerves increased with age in the IL-2+/+ mice. However, no such increases were seen in the mice with a disrupted IL-2 gene. Instead, the volume densities of enteroglucagon, serotonin cells and substance P (SP), vasoactive intestinal polypeptide (VIP) and total myenteric nerves were lower in the older IL-2+/- and IL-2-/- mice compared with the wild type. The other was disease-related. Polypeptide YY (PYY) cells and tissue levels of PYY, SP and VIP were significantly decreased in the IL-2-/- mice during the course of bowel inflammation compared with the healthy IL-2+/- and IL-2+/+ controls. These findings indicate that colonic neuroendocrine alterations did occur in the mice with a disrupted IL-2 gene and diminished local IL-2 level, suggesting a role of IL-2 in the regulation of the neuroendocrine system and a prevalent interaction between the immune and neuroendocrine systems in normal colon. On the other hand, there were some changes that seemed to correlate with the bowel inflammatory process. They might be associated with the impaired function in inflamed gut and contribute to the development and/or prolongation of disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844519      PMCID: PMC1905567          DOI: 10.1046/j.1365-2249.2000.01255.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

Review 1.  Recent developments in the immunology of inflammatory bowel disease.

Authors:  T T MacDonald; G Monteleone; S L Pender
Journal:  Scand J Immunol       Date:  2000-01       Impact factor: 3.487

2.  Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

Authors:  T E Adrian; J S Thompson; E M Quigley
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells.

Authors:  H Komano; Y Fujiura; M Kawaguchi; S Matsumoto; Y Hashimoto; S Obana; P Mombaerts; S Tonegawa; H Yamamoto; S Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 4.  Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance.

Authors:  I Horak; J Löhler; A Ma; K A Smith
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

Review 5.  Mediators of inflammation in chronic inflammatory bowel disease.

Authors:  O H Nielsen; J Rask-Madsen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 6.  Neuronal factors modulating immunity.

Authors:  A M Stanisz
Journal:  Neuroimmunomodulation       Date:  1994 Jul-Aug       Impact factor: 2.492

7.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Authors:  A Macpherson; U Y Khoo; I Forgacs; J Philpott-Howard; I Bjarnason
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

8.  Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.

Authors:  C Lundqvist; S Melgar; M M Yeung; S Hammarström; M L Hammarström
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

9.  Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis.

Authors:  U Keränen; T Kiviluoto; H Järvinen; N Bäck; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

10.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.

Authors:  J J Worthington; F Reimann; F M Gribble
Journal:  Mucosal Immunol       Date:  2017-08-30       Impact factor: 7.313

2.  Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse.

Authors:  Malin Sund; Li Li Xu; Arman Rahman; Bi-Feng Qian; Marie-Louise Hammarström; Ake Danielsson
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

3.  CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.

Authors:  Huaqing Wang; Justin Steeds; Yasuaki Motomura; Yikang Deng; Monica Verma-Gandhu; Rami T El-Sharkawy; John T McLaughlin; Richard K Grencis; Waliul I Khan
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

4.  High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis.

Authors:  Magdy El-Salhy; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

5.  IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).

Authors:  Maja Cigrovski Berković; Mladen Jokić; Jasminka Marout; Senka Radosević; Vanja Zjacić-Rotkvić; Sanja Kapitanović
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

Review 6.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

7.  Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis.

Authors:  Magdy El-Salhy; Kazuo Umezawa
Journal:  Mol Med Rep       Date:  2016-06-27       Impact factor: 2.952

Review 8.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

9.  Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk
Journal:  Mol Med Rep       Date:  2016-10-31       Impact factor: 2.952

10.  Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja
Journal:  Mol Med Rep       Date:  2016-12-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.